Prospectus

Definium Therapeutics, Inc. Filed 2022-09-27 Acc 0001193125-22-252178

Documents 1

2022-09-29 8-K Material agreement · Other events
2022-09-29 424B5 Prospectus
2022-09-27 424B5 Prospectus
2022-09-27 4 Chief Medical Officer sold 1,205 shares at an average $5.70 ($6,870)
2022-09-27 4 Chief Executive Officer sold 1,264 shares at $5.51 ($6,965)

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading d373470d424b5.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…